Abbvie Inc Stock Performance
| ABBV Stock | USD 224.81 0.46 0.21% |
The firm shows a Beta (market volatility) of -0.0555, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning AbbVie are expected to decrease at a much lower rate. During the bear market, AbbVie is likely to outperform the market. At this point, AbbVie Inc has a negative expected return of -0.0092%. Please make sure to confirm AbbVie's potential upside, and the relationship between the jensen alpha and rate of daily change , to decide if AbbVie Inc performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days AbbVie Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable fundamental drivers, AbbVie is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors. ...more
Actual Historical Performance (%)
One Day Return 0.21 | Five Day Return (1.58) | Year To Date Return (1.96) | Ten Year Return 306.68 | All Time Return 542.31 |
Forward Dividend Yield 0.0296 | Payout Ratio | Forward Dividend Rate 6.65 | Dividend Date 2026-02-17 | Ex Dividend Date 2026-04-15 |
1 | Top Medical Stocks To Add to Your Watchlist February 4th | 02/04/2026 |
2 | Silver and Gold Prices Are Volatile. Buy This ETF for Safety This Year | 02/10/2026 |
3 | 1 Reason Im Never Selling AbbVie Stock | 02/12/2026 |
4 | Where is AbbVie Inc. Headed According to the Street | 02/13/2026 |
| AbbVie dividend paid on 17th of February 2026 | 02/17/2026 |
6 | Peering Into AbbVie Incs Recent Short Interest | 02/18/2026 |
7 | 3 Stocks to Buy and Hold for 2026 and Beyond | 02/19/2026 |
| Begin Period Cash Flow | 5.5 B | |
| Total Cashflows From Investing Activities | -6.6 B | |
| Free Cash Flow | 19 B |
AbbVie Relative Risk vs. Return Landscape
If you would invest 22,768 in AbbVie Inc on November 23, 2025 and sell it today you would lose (287.00) from holding AbbVie Inc or give up 1.26% of portfolio value over 90 days. AbbVie Inc is currently does not generate positive expected returns and assumes 1.5561% risk (volatility on return distribution) over the 90 days horizon. In different words, 13% of stocks are less volatile than AbbVie, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
AbbVie Target Price Odds to finish over Current Price
The tendency of AbbVie Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 224.81 | 90 days | 224.81 | about 44.01 |
Based on a normal probability distribution, the odds of AbbVie to move above the current price in 90 days from now is about 44.01 (This AbbVie Inc probability density function shows the probability of AbbVie Stock to fall within a particular range of prices over 90 days) .
AbbVie Price Density |
| Price |
Predictive Modules for AbbVie
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as AbbVie Inc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.AbbVie Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. AbbVie is not an exception. The market had few large corrections towards the AbbVie's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold AbbVie Inc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of AbbVie within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.03 | |
β | Beta against Dow Jones | -0.06 | |
σ | Overall volatility | 4.78 | |
Ir | Information ratio | -0.07 |
AbbVie Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of AbbVie for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for AbbVie Inc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| AbbVie Inc generated a negative expected return over the last 90 days | |
| AbbVie Inc currently holds 26.29 B in liabilities with Debt to Equity (D/E) ratio of 4.37, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. AbbVie Inc has a current ratio of 0.91, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about AbbVie's use of debt, we should always consider it together with its cash and equity. | |
| Over 76.0% of AbbVie shares are held by institutions such as insurance companies | |
| On 17th of February 2026 AbbVie paid $ 1.73 per share dividend to its current shareholders | |
| Latest headline from finance.yahoo.com: 3 Stocks to Buy and Hold for 2026 and Beyond |
AbbVie Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of AbbVie Stock often depends not only on the future outlook of the current and potential AbbVie's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. AbbVie's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.8 B | |
| Cash And Short Term Investments | 5.2 B | |
| Forward Annual Dividend Rate | 6.65 | |
| Shares Float | 1.8 B |
AbbVie Fundamentals Growth
AbbVie Stock prices reflect investors' perceptions of the future prospects and financial health of AbbVie, and AbbVie fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on AbbVie Stock performance.
| Return On Equity | 0.11 | ||||
| Return On Asset | 0.0959 | ||||
| Profit Margin | 0.07 % | ||||
| Operating Margin | 0.35 % | ||||
| Current Valuation | 472.22 B | ||||
| Shares Outstanding | 1.77 B | ||||
| Price To Earning | 21.28 X | ||||
| Price To Book | 50.46 X | ||||
| Price To Sales | 6.48 X | ||||
| Revenue | 61.16 B | ||||
| Gross Profit | 43.82 B | ||||
| EBITDA | 28.29 B | ||||
| Net Income | 4.23 B | ||||
| Cash And Equivalents | 11.88 B | ||||
| Cash Per Share | 6.72 X | ||||
| Total Debt | 26.29 B | ||||
| Debt To Equity | 4.37 % | ||||
| Current Ratio | 0.93 X | ||||
| Book Value Per Share | (1.50) X | ||||
| Cash Flow From Operations | 19.03 B | ||||
| Earnings Per Share | 2.36 X | ||||
| Market Capitalization | 396.51 B | ||||
| Total Asset | 5.46 B | ||||
| Retained Earnings | (7.9 B) | ||||
| Working Capital | (13.17 B) | ||||
| Current Asset | 16.31 B | ||||
| Current Liabilities | 10.89 B | ||||
About AbbVie Performance
Evaluating AbbVie's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if AbbVie has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if AbbVie has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 103.82 | 93.34 | |
| Return On Tangible Assets | 0.77 | 0.81 | |
| Return On Capital Employed | 3.89 | 4.08 | |
| Return On Assets | 0.77 | 0.81 | |
| Return On Equity | (1.63) | (1.54) |
Things to note about AbbVie Inc performance evaluation
Checking the ongoing alerts about AbbVie for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for AbbVie Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| AbbVie Inc generated a negative expected return over the last 90 days | |
| AbbVie Inc currently holds 26.29 B in liabilities with Debt to Equity (D/E) ratio of 4.37, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. AbbVie Inc has a current ratio of 0.91, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about AbbVie's use of debt, we should always consider it together with its cash and equity. | |
| Over 76.0% of AbbVie shares are held by institutions such as insurance companies | |
| On 17th of February 2026 AbbVie paid $ 1.73 per share dividend to its current shareholders | |
| Latest headline from finance.yahoo.com: 3 Stocks to Buy and Hold for 2026 and Beyond |
- Analyzing AbbVie's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether AbbVie's stock is overvalued or undervalued compared to its peers.
- Examining AbbVie's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating AbbVie's management team can have a significant impact on its success or failure. Reviewing the track record and experience of AbbVie's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of AbbVie's stock. These opinions can provide insight into AbbVie's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for AbbVie Stock Analysis
When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.